Variant report
Variant | nsv970168 |
---|---|
Chromosome Location | chr6:133318534-133319034 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs545592991 | chr6:133318540-133318541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs199571081 | chr6:133318551-133318552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2011426 | chr6:133318562-133318563 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs531165539 | chr6:133318578-133318579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs117115597 | chr6:133318586-133318587 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563287537 | chr6:133318589-133318590 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116552510 | chr6:133318641-133318642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548711964 | chr6:133318697-133318698 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188589077 | chr6:133318720-133318721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138635861 | chr6:133318722-133318723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9493495 | chr6:133318759-133318760 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs562075248 | chr6:133318762-133318763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs571086377 | chr6:133318768-133318769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs536893942 | chr6:133318773-133318774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551042374 | chr6:133318775-133318776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs141246040 | chr6:133318787-133318788 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs180695751 | chr6:133318814-133318815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73549894 | chr6:133318818-133318819 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs540988700 | chr6:133318887-133318888 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs114876541 | chr6:133318897-133318898 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539325253 | chr6:133318905-133318906 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372859855 | chr6:133318918-133318919 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs55930751 | chr6:133318924-133318925 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs1886577 | chr6:133318929-133318930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs112846490 | chr6:133318958-133318959 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112816305 | chr6:133319004-133319005 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs144983373 | chr6:133319008-133319009 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs542574250 | chr6:133319016-133319017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs558905940 | chr6:133319029-133319030 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs528102142 | chr6:133319030-133319031 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Autism | 22495311 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastric cancer | 17908304 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21785460 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Leukemia | 18688285 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:133315200-133322000 | Weak transcription | Psoas Muscle | Psoas |
2 | chr6:133317400-133319000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
3 | chr6:133317400-133319800 | Weak transcription | Brain Substantia Nigra | brain |
4 | chr6:133317600-133318800 | Weak transcription | Brain Hippocampus Middle | brain |
5 | chr6:133317600-133320000 | Weak transcription | HSMMtube | muscle |
6 | chr6:133318000-133319000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
7 | chr6:133318800-133322400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
8 | chr6:133319000-133319400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
9 | chr6:133319000-133319400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
10 | chr6:133319000-133319600 | Enhancers | Cortex derived primary cultured neurospheres | brain |